SEC Company Response from MDxHealth SA (MDXH) — Feb 12, 2026
MDxHealth SA
Date: Feb. 12, 2026 · CIK: 0001872529 · Accession: 0001213900-26-015510
AI Filing Summary & Sentiment
File numbers found in text: 333-292463
Show Raw Text
CORRESP 1 filename1.htm MDxHealth SA Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium February 12, 2026 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Margaret Sawicki Re: MDxHealth SA Registration Statement on Form F-3 (File No. 333-292463) Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), registrant MDxHealth SA (the "Registrant") hereby respectfully requests that the above-referenced Registration Statement on Form F-3 be declared effective at 4:00 p.m., Eastern Time, on Tuesday, February 17, 2026, or as soon thereafter as is practicable or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted. We understand that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the Securities Act as they relate to the issuance of the securities covered by the Registration Statement. Sincerely, /s/ Joseph Sollee Joseph Sollee EVP Corporate Development and General Counsel